EU agreed 15.50 euros per dose for Pfizer vaccine


The purchase price, and that is confidential & was negotiated for all in all , 300 zillion doses, is a little lower than the $19.50 a picture the United States agreed to buy a first shipment of 100 million doses of the same vaccine, in line with what Reuters claimed in November.

The EU booklet dated Nov. eighteen was circulated internally right after the EU announced its supply offer with Pfizer and its German partner BioNTech on Nov. 11.

The EU drug regulator is expected to decide on Monday on acceptance for the Pfizer vaccine after the photo was authorised in several countries, like Britain as well as the United States.

On Thursday Belgian declare secretary with the budget Eva De Bleeker published on Twitter a dining room table with costs Belgium would pay pharmaceutical companies for the COVID-19 vaccines of theirs. She retracted the article shortly after posting.

In that dining room table the Pfizer vaccine was suggested as costing Belgium twelve euros ($14.6) a dose, top many to think this was the total price agreed by way of the EU.

Other vaccines in the table were also shown with rates lower than rates disclosed by EU sources.

“There is always a total fee and a cost upon delivery,” an EU official required in talks with vaccine makers told Reuters when made to clarify the big difference between the EU and Belgian prices.

A spokesman for De Bleeker declined to comment on Monday, citing confidentiality requirements, but pointed to what De Bleeker told the Belgian parliament previous week. In that public hearing, De Beeker said Belgium’s budgeted price tags were still partial.

Underneath EU advance purchase deals for COVID 19 vaccines, the bloc concurs upfront payments with businesses to secure doses before they are approved. Following approvals, EU governments can pay the rest to buy reserved doses.

The EU has not revealed the initial transaction agreed with Pfizer.

But, it stated in October which it paid aproximatelly 1 billion euros found in downpayments to AstraZeneca, Sanofi and Johnson & Johnson for their shots, with a further 1.45 billion euros budgeted for upfront payments to Pfizer BioNTech, Curevac and Moderna.

It’s since agreed supply deals with all six companies and it is negotiating a seventh arrangement with Novavax.

Leave a Reply

Your email address will not be published. Required fields are marked *